Metavallon VC Invests in Anacalypsis Therapeutics – A Pre-Seed Financing Round to Advance Potential New Parkinson’s Disease Treatment
- Posted by Henry Umunnakwe
- On September 21, 2026
- Anacalypsis Therapeutics, Biotechnology, Drug Discovery, Metavallon VC, Parkinson’s Disease
In the first investment by a Greece-based VC fund in a homegrown drug discovery biotech, the funding will advance Anacalypsis’ lead drug candidate, AT001, and support the development of its broader pipeline. Athens, Greece – 21 September 2026 – Anacalypsis Therapeutics, a Greece-based biotechnology company developing new treatments for Parkinson’s disease and other neurodegenerative […]
Read More



